Inhibitory effect of taspine derivative TAD1822-7 on tumor cell growth and angiogenesis via suppression of EphrinB2 and related signaling pathways
By: Rui Liu, Runze Yu, Yuxin Cui, Mengying Fan, Bo Wang and Yanmin Zhang
Authors
Rui Liu
School of Pharmacy, Xi’an Jiaotong University, Xi’an, China
Runze Yu
School of Pharmacy, Xi’an Jiaotong University, Xi’an, China
Yuxin Cui
School of Pharmacy, Xi’an Jiaotong University, Xi’an, China
Mengying Fan
School of Pharmacy, Xi’an Jiaotong University, Xi’an, China
Bo Wang
School of Pharmacy, Xi’an Jiaotong University, Xi’an, China
Language: English
Page range: 423 - 431
Accepted on: Dec 3, 2018
Published on: Jun 26, 2019
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2019 Rui Liu, Runze Yu, Yuxin Cui, Mengying Fan, Bo Wang, Yanmin Zhang, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.